J&J Offers Sliding Timeframe for Covid Boosters Based on Individual Patient and Geographic Need

Johnson and Johnson’s one-shot Covid vaccine gets a solid efficacy boost with second shot administered two months after primary vaccination, but the company will argue based on much more limited data that a longer window between shots may be preferable for some populations.  

J&J Janssen sign
J&J’s COVID-19 booster application heads to the FDA’s VRBPAC on 15 October • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers